Aemetis Inc. (AMTX) Insider Trading

Last 12 months

Insiders sold $21k and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Director Timothy Alan Simon sold $21k on Jun 10, 19% of their stake, outside a plan. The last open-market buy by an executive or director was in Dec 2021.

Net open-market

−$21k

0 buys · 1 sale

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

0 / 1

executives and directors

Last open-market buy

Dec 2021

Dec 20, 2021

Get an email when AMTX's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Jun 10	Timothy Alan Simon Director	SoldNo plan	10,000	$2.05	$21k	19%	Form 4
Aug 14, 2025	Francis P Barton Director	SoldNo plan 4 parts	26,452	$2.53 average	$67k	11%	Form 4

Jun 10No plan
Timothy Alan Simon
Director · sold 10,000 at $2.05
$21k
19% of stake
Aug 14, 2025No plan
Francis P Barton
Director · sold 26,452 at avg $2.53
$67k
11% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch AMTX, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Industrial Organic Chemicals

GEVOGevo Inc.

FFFutureFuel Corp

CDXSCodexis Inc.

LNZALanzaTech Global Inc.

TANHTantech Holdings Ltd.

REXRex American Resources Corporation

ALTOAlto Ingredients Inc.

WLKPWestlake Chemical Partners LP

Spot a number that looks wrong? Check it in AMTX's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing AMTX

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.